dihexa human clinical trials status seven orders of magnitude more potent than bdnf trial Dihexa shows neurotrophic activity exceeding in preclinical studies DIHEXA dihexa clinical trial human trials

BPC-157 peptide (Body Protection Compound-157) stands apart from nearly every other synthetic research peptide for one striking reason: it originates from a protein naturally found in human gastric juice, yet it demonstrates repair activity across at least nine distinct tissue systems in published preclinical studies

Genome Biol

Discard the used Pen in your household trash or FDA-cleared sharps disposal container after you have removed the needle

It is meant to be used together with a lifestyle therapy regimen involving a reduced calorie diet and increased physical activity

Third, the peptides growth hormone receptor upregulation has implications for tissue repair